Comparative analysis of methPLIER-CTD between pan-negative and EGFR-mutated lung cancer patients identified 841 lung cancer pan-negative case-specific DMPs associated with the drug-related gene set and genomic regions of interest. This evidence concerns the gene EGFR and lung carcinoma.